Published online before print January 19, 2004, doi: 10.1161/01.HYP.0000111585.76299.f7
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;43:477.)
© 2004 American Heart Association, Inc.
Scientific Contribution |
Positional Identification of Hypertension Susceptibility Genes on Chromosome 2
From the Human Genetics Center and Institute of Molecular Medicine (R.A.B., E.B.), University of Texas Health Science Center at Houston; the McKusick-Nathans Institute of Genetic Medicine (A.C.), Johns Hopkins University School of Medicine, Baltimore, Md; the Department of Preventive Medicine and Epidemiology (R.S.C.), Loyola University Medical Center, Maywood, Ill; the Section of Preventive Medicine and Epidemiology (C.E.), Boston University Medical Center, Boston, Mass; the Cardiovascular Genetics Division (S.C.H.), University of Utah, Salt Lake City; the Division of Biostatistics (M.A.P.), Washington University School of Medicine, St. Louis, Mo; the Division of Hypertension and Department of Internal Medicine (S.T.T.), Mayo Clinic, Rochester, Minn; and the Division of Hypertension (A.B.W.), University of Michigan, Ann Arbor.
Correspondence to Eric Boerwinkle, PhD, 1200 Herman Pressler, RAS E-453 Houston, Texas 77030. E-mail Eric.Boerwinkle{at}uth.tmc.edu
Chromosome 2 has been consistently identified as a genomic region with genetic linkage evidence suggesting that one or more loci contributes to blood pressure and hypertension status. As with all complex disease traits, following-up linkage evidence to identify the underlying susceptibility gene(s) is an arduous yet biologically and clinically important task. Using combined positional candidate gene methods, the Family Blood Pressure Program (FBPP) has concentrated efforts in narrowing a large region of chromosome 2, demonstrating evidence for linkage in several populations, and identifying underlying candidate hypertension susceptibility gene(s). Initial informatics efforts identified the boundaries of the region and the known genes within it. A total of 82 polymorphic sites in 8 genes were genotyped in a large hypothesis-generating sample consisting of 1640 African Americans, 1339 whites, and 1616 Mexican Americans. After resampling-based false discovery adjustment, SLC4A5, a sodium bicarbonate transporter, was identified as a primary candidate gene for hypertension. Polymorphisms in SLC4A5 were subsequently genotyped and analyzed for validation in two other subcomponents of the FBPP, each contributing African Americans (N=461; N=778) and whites (N=550; N=967). Again, single nucleotide polymorphisms within this gene were significantly associated with blood pressure levels and hypertension status. Although not identifying a single causal gene variant that is significantly associated with blood pressure levels and hypertension status across all samples, the results further implicate SLC4A5 as a candidate hypertension susceptibility gene. Moreover, the present study validates previous evidence for one or more genes on chromosome 2 that influence hypertension-related phenotypes in the population-at-large.
Key Words: hypertension • genes • blood pressure • association • genetic linkage
This article has been cited by other articles:
 |
|
 |
|
  W. F. Boron, L. Chen, and M. D. Parker Modular structure of sodium-coupled bicarbonate transporters J. Exp. Biol., June 1, 2009; 212(11): 1697 - 1706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. O. Tayo, A. Luke, X. Zhu, A. Adeyemo, and R. S. Cooper Association of Regions on Chromosomes 6 and 7 With Blood Pressure in Nigerian Families Circ Cardiovasc Genet, February 1, 2009; 2(1): 38 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Kao, P. Sassani, R. Azimov, A. Pushkin, N. Abuladze, J. Peti-Peterdi, W. Liu, D. Newman, and I. Kurtz Oligomeric Structure and Minimal Functional Unit of the Electrogenic Sodium Bicarbonate Cotransporter NBCe1-A J. Biol. Chem., September 26, 2008; 283(39): 26782 - 26794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Gurnett, R. Veile, J. Zempel, L. Blackburn, M. Lovett, and A. Bowcock Disruption of Sodium Bicarbonate Transporter SLC4A10 in a Patient With Complex Partial Epilepsy and Mental Retardation Arch Neurol, April 1, 2008; 65(4): 550 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kato, T. Miyata, Y. Tabara, T. Katsuya, K. Yanai, H. Hanada, K. Kamide, J. Nakura, K. Kohara, F. Takeuchi, et al. High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project Hum. Mol. Genet., February 14, 2008; 17(4): 617 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Hunt Tyrosine Hydroxylase: Another Piece of the Genetics of Hypertension Puzzle Circulation, August 28, 2007; 116(9): 970 - 972. [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Arnett and for the Writing Group Summary of the American Heart Association's Scientific Statement on the Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1682 - 1686. [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Morrison, L. A. Bare, L. E. Chambless, S. G. Ellis, M. Malloy, J. P. Kane, J. S. Pankow, J. J. Devlin, J. T. Willerson, and E. Boerwinkle Prediction of Coronary Heart Disease Risk using a Genetic Risk Score: The Atherosclerosis Risk in Communities Study Am. J. Epidemiol., July 1, 2007; 166(1): 28 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al. Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, June 5, 2007; 115(22): 2878 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kalmyrzaev, A. Aldashev, M. Khalmatov, A. Polupanov, A. Jumagulova, L. Mamanova, M. R. Wilkins, and M. Town Genome-Wide Scan for Premature Hypertension Supports Linkage to Chromosome 2 in a Large Kyrgyz Family Hypertension, November 1, 2006; 48(5): 908 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pushkin and I. Kurtz SLC4 base (HCO3-, CO32-) transporters: classification, function, structure, genetic diseases, and knockout models Am J Physiol Renal Physiol, March 1, 2006; 290(3): F580 - F599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Hunt, Y. Xin, L. L. Wu, R. M. Cawthon, H. Coon, S. J. Hasstedt, and P. N. Hopkins Sodium Bicarbonate Cotransporter Polymorphisms Are Associated With Baseline and 10-Year Follow-Up Blood Pressures Hypertension, March 1, 2006; 47(3): 532 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Padmanabhan, C. Wallace, P. B. Munroe, R. Dobson, M. Brown, N. Samani, D. Clayton, M. Farrall, J. Webster, M. Lathrop, et al. Chromosome 2p Shows Significant Linkage to Antihypertensive Response in the British Genetics of Hypertension Study Hypertension, March 1, 2006; 47(3): 603 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Chen, S. Li, S. R Srinivasan, E. Boerwinkle, and G. S. Berenson Autosomal Genome Scan for Loci Linked to Blood Pressure Levels and Trends Since Childhood: The Bogalusa Heart Study Hypertension, May 1, 2005; 45(5): 954 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Meneton, X. Jeunemaitre, H. E. de Wardener, and G. A. Macgregor Links Between Dietary Salt Intake, Renal Salt Handling, Blood Pressure, and Cardiovascular Diseases Physiol Rev, April 1, 2005; 85(2): 679 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Dominiczak, D. Graham, M. W. McBride, N. J.R. Brain, W. K. Lee, F. J. Charchar, M. Tomaszewski, C. Delles, and C. A. Hamilton Cardiovascular Genomics and Oxidative Stress Hypertension, April 1, 2005; 45(4): 636 - 642. [Abstract] [Full Text] [PDF]
|
|